Bill Text: TX HB3485 | 2019-2020 | 86th Legislature | Introduced
Bill Title: Relating to the billing codes used for the administration of tissue plasminogen activator by ambulance providers under the Medicaid and Medicare programs.
Spectrum: Partisan Bill (Republican 1-0)
Status: (Introduced - Dead) 2019-03-18 - Referred to Human Services [HB3485 Detail]
Download: Texas-2019-HB3485-Introduced.html
86R3759 MM-D | ||
By: Davis of Harris | H.B. No. 3485 |
|
||
|
||
relating to the billing codes used for the administration of tissue | ||
plasminogen activator by ambulance providers under the Medicaid and | ||
Medicare programs. | ||
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: | ||
SECTION 1. Subchapter B, Chapter 531, Government Code, is | ||
amended by adding Section 531.024136 to read as follows: | ||
Sec. 531.024136. MEDICAID BILLING CODE FOR TISSUE | ||
PLASMINOGEN ACTIVATOR ADMINISTERED BY AMBULANCE PROVIDERS. The | ||
executive commissioner by rule shall adopt a specific procedure or | ||
other billing code under Medicaid for the administration of tissue | ||
plasminogen activator by an ambulance provider. | ||
SECTION 2. As soon as possible after the effective date of | ||
this Act, the Health and Human Services Commission shall request | ||
that the Centers for Medicare and Medicaid Services or other | ||
appropriate federal agency adopt a specific procedure or other | ||
billing code for the administration of tissue plasminogen activator | ||
by an ambulance provider under the Medicare program. | ||
SECTION 3. If before implementing any provision of this Act | ||
a state agency determines that a waiver or authorization from a | ||
federal agency is necessary for implementation of that provision, | ||
the agency affected by the provision shall request the waiver or | ||
authorization and may delay implementing that provision until the | ||
waiver or authorization is granted. | ||
SECTION 4. This Act takes effect September 1, 2019. |